Cargando…
A case for newborn screening for pyridoxine-dependent epilepsy
Pyridoxine-dependent epilepsy due to mutations in ALDH7A1 (PDH-ALDH7A1) is a highly treatable developmental and epileptic encephalopathy. Pharmacologic doses of pyridoxine are associated with dramatic clinical seizure improvement, and most patients achieve adequate seizure control with pyridoxine al...
Autores principales: | Coughlin, Curtis R., Tseng, Laura A., van Karnebeek, Clara D.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958922/ https://www.ncbi.nlm.nih.gov/pubmed/35217564 http://dx.doi.org/10.1101/mcs.a006197 |
Ejemplares similares
-
Metabolite Identification Using Infrared Ion Spectroscopy—Novel
Biomarkers for Pyridoxine-Dependent Epilepsy
por: van Outersterp, Rianne E., et al.
Publicado: (2021) -
Pyridoxine-dependent epilepsy (PDE-ALDH7A1) in adulthood: A Dutch pilot study exploring clinical and patient-reported outcomes
por: Tseng, L.A., et al.
Publicado: (2022) -
Pyridoxine-Dependent Epilepsy in Zebrafish Caused by Aldh7a1 Deficiency
por: Pena, Izabella A., et al.
Publicado: (2017) -
The psychological impact on parents of children with pyridoxine-dependent epilepsy
por: Boujelbene, I., et al.
Publicado: (2023) -
The progressive intellectual and neurological deterioration study: a game changer
por: van Karnebeek, Clara DM
Publicado: (2020)